Systemic Mastocytosis Associated with Chronic Idiopathic Myelofibrosis

This publication has 36 references indexed in Scilit:

• A Gain-of-Function Mutation ofJAK2in Myeloproliferative Disorders
  New England Journal of Medicine, 2005
• Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
  Cancer Cell, 2005
• A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
  Nature, 2005
• Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge
  Journal of Clinical Pathology, 2004
• CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy
  Blood, 2003
• Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis
  Experimental Hematology, 2000
• Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
  Journal of Clinical Investigation, 1993
• Classification and Diagnosis of Mastocytosis: Current Status
  Journal of Investigative Dermatology, 1991
• Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.
  Journal of Histochemistry & Cytochemistry, 1981
• Mast cells and mast cell neoplasia: a review*
  Histopathology, 1979